Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Current Debt (2015 - 2019)

Updated

Skinvisible (SKVI) recorded Current Debt of -$3,395 in Q2 2019.

Analysis

Skinvisible (SKVI) Current Debt (2015 - 2019) Analysis & Trends

On a TTM basis, Skinvisible's Current Debt came in at $595.00 as of Jun 30, 2019, down 85.1% year-over-year; for FY2018, it came in at $3,990, down 92.8% from FY2017.

  • Annual Current Debt has a four-year compound annual growth rate of -48.2% (FY2014 to FY2018).
  • Across earlier years, Current Debt came in at $55,475 in FY2017, -$1,340 in FY2016, $1,340 in FY2015 (-97.6%) and $55,475 in FY2014.
  • The Q2 2019 figure is the lowest quarterly Current Debt since Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Skinvisible 1.08 Mn 1.07 Mn 5,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -3,395.00
Mar 31, 2019 3,990.00
Mar 31, 2018 3,990.00
Mar 31, 2017 55,475.00
Dec 31, 2016 -2,886.00
Sep 30, 2016 624.00
Jun 30, 2016 -6,098.00
Mar 31, 2016 7,020.00
Dec 31, 2015 -31,447.00
Sep 30, 2015 -22,688.00
Mar 31, 2015 55,475.00
API Access

Skinvisible Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=SKVI&period=max&api_key=YOUR_API_KEY